Trademarkia Logo

Canada

C$
Trademark Search in Canada
MOZART THERAPEUTICS

View On IC.GC.CA

MOZART THERAPEUTICS
SEARCHED

on 31 May 2024

Last Applicant/ Owned by

MOZART THERAPEUTICS INC.

410 W Harrison Street, Suite 150Seattle WA 98119

US

Serial Number

2242933 filed on 24th Jan 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

MOZART THERAPEUTICS

Trademark usage description

pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflam Read More

Classification Information

Class [005]
Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, gastrointestinal diseases and disorders, and other related diseases and disorders; biological products and preparations, for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; cell therapy products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; therapeutic products and preparations, for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; pharmaceutical, biological, cell therapy, therapeutic and medicinal products and preparations for use in combination with other therapies for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, cancer and other related diseases and disorders; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, gastrointestinal diseases and disorders, and other related diseases and disorders.

Classification kind code

12

Class [042]
Pharmaceutical research and development in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; medical, pharmaceutical, therapeutic and scientific research in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; medical, pharmaceutical, therapeutic and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; clinical research and testing in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; clinical research and testing in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; conducting clinical trials in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer gastrointestinal diseases and disorders, and other related diseases and disorders; providing medical, clinical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders.

Classification kind code

12

Mark Details

Serial Number

2242933

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 31st May 2024		Search Recorded
Submitted for opposition 20
on 31st May 2024		Examiner's First Report
Submitted for opposition 223
on 31st May 2024		Total Provisional Refusal
Submitted for opposition 256
on 2th Jan 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th Mar 2023		Agent Changed
Submitted for opposition 257
on 2th Mar 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Mar 2023		Formalized
Submitted for opposition 1
on 1st Mar 2023		Created
Submitted for opposition 228
on 24th Jan 2023		International Registration
Submitted for opposition 30
on 24th Jan 2023		Filed